Citurgia Biochemicals Ltd.
BSE: CITURGIA · Commodity Chemicals
Snapshot
Unlock Citurgia Biochemicals Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Citurgia Biochemicals Limited is an Indian chemical manufacturer established in 1974, specialising in the production of citric acid and calcium carbonate. The company serves diverse industrial applications across the food, beverage, and pharmaceutical sectors from its manufacturing facility in Rishikesh.
Business Model
The company generates revenue through the large-scale manufacturing and supply of biochemical products to industrial clients. It operates as a public entity listed on the Bombay Stock Exchange, leveraging its long-standing operational history to maintain market presence.
- Years of Operation:50
Management Commentary
The company is currently managed by a board of directors, with leadership provided by Executive Director Kashi Nath Jha. Management focuses on maintaining corporate governance and operational continuity as the firm marks its 50th year of business.
Growth Outlook
Growth is expected to be driven by the sustained demand for citric acid and calcium carbonate within the food and pharmaceutical industries. The company continues to leverage its established manufacturing infrastructure to support its long-term market position.
Key Risks
- Commodity Price Volatility. Fluctuations in the cost of raw materials can significantly impact the profit margins of chemical manufacturers.
- Regulatory Compliance. The chemical industry is subject to stringent environmental and safety regulations that may necessitate ongoing capital expenditure.
- Market Competition. The company faces intense competition from both domestic and international players in the citric acid and biochemical markets.
Start your research today
Unlock AI insights, financials, peers and live data on Citurgia Biochemicals Ltd. and 5,000+ companies — free.
Peers · Commodity Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Citurgia Biochemicals Ltd.CITURGIA | ₹1,421 Cr | — | — | — | — | — | — | — |
IG Petrochemicals LimitedIGPL | ₹1,747 Cr | 21.40 | 9.03 | -0.9% | 11.1% | 6.1% | 9.8% | +27.1% |
Indo Borax & Chemicals LimitedINDOBORAX | ₹1,652 Cr | 29.32 | 24.56 | 29.7% | 28.7% | 15.6% | 20.4% | +112.5% |
The Andhra Sugars LimitedANDHRSUGAR | ₹1,349 Cr | 12.81 | 5.11 | 16.5% | 10.3% | 6.7% | 7.9% | +28.7% |
Innovassynth Technologies (India) LimitedINOVSYNTH | ₹1,312 Cr | 470.83 | 642.55 | — | 3.0% | 5.0% | -2.6% | +45.8% |
TGV SraacTGVSL | ₹1,178 Cr | 8.92 | 4.07 | — | 18.8% | 10.2% | 12.6% | -15.8% |
As of Mar 2026
Financials
Citurgia Biochemicals Ltd.
BSE: CITURGIA · Commodity Chemicals
Snapshot
Unlock Citurgia Biochemicals Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Citurgia Biochemicals Limited is an Indian chemical manufacturer established in 1974, specialising in the production of citric acid and calcium carbonate. The company serves diverse industrial applications across the food, beverage, and pharmaceutical sectors from its manufacturing facility in Rishikesh.
Business Model
The company generates revenue through the large-scale manufacturing and supply of biochemical products to industrial clients. It operates as a public entity listed on the Bombay Stock Exchange, leveraging its long-standing operational history to maintain market presence.
- Years of Operation:50
Management Commentary
The company is currently managed by a board of directors, with leadership provided by Executive Director Kashi Nath Jha. Management focuses on maintaining corporate governance and operational continuity as the firm marks its 50th year of business.
Growth Outlook
Growth is expected to be driven by the sustained demand for citric acid and calcium carbonate within the food and pharmaceutical industries. The company continues to leverage its established manufacturing infrastructure to support its long-term market position.
Key Risks
- Commodity Price Volatility. Fluctuations in the cost of raw materials can significantly impact the profit margins of chemical manufacturers.
- Regulatory Compliance. The chemical industry is subject to stringent environmental and safety regulations that may necessitate ongoing capital expenditure.
- Market Competition. The company faces intense competition from both domestic and international players in the citric acid and biochemical markets.
Start your research today
Unlock AI insights, financials, peers and live data on Citurgia Biochemicals Ltd. and 5,000+ companies — free.
Peers · Commodity Chemicals
As of Mar 2026